Denis Claude Roy
Citée par
Citée par
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
WJ Song, MG Sullivan, RD Legare, S Hutchings, X Tan, D Kufrin, ...
Nature genetics 23 (2), 166-175, 1999
Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ...
New England Journal of Medicine 325 (22), 1525-1533, 1991
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts
AM Eiring, JG Harb, P Neviani, C Garton, JJ Oaks, R Spizzo, S Liu, ...
Cell 140 (5), 652-665, 2010
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
I Fares, J Chagraoui, Y Gareau, S Gingras, R Ruel, N Mayotte, E Csaszar, ...
Science 345 (6203), 1509-1512, 2014
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ...
Cancer cell 8 (5), 355-368, 2005
Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome.
MH Lachapelle, P Miron, R Hemmings, DC Roy
Journal of immunology (Baltimore, Md.: 1950) 156 (10), 4027-4034, 1996
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia
P Neviani, R Santhanam, JJ Oaks, AM Eiring, M Notari, BW Blaser, S Liu, ...
The Journal of clinical investigation 117 (9), 2408-2421, 2007
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
S Assouline, B Culjkovic, E Cocolakis, C Rousseau, N Beslu, A Amri, ...
Blood 114 (2), 257-260, 2009
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
P Neviani, JG Harb, JJ Oaks, R Santhanam, CJ Walker, JJ Ellis, ...
The Journal of clinical investigation 123 (10), 4144-4157, 2013
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
M Notari, P Neviani, R Santhanam, BW Blaser, JS Chang, A Galietta, ...
Blood 107 (6), 2507-2516, 2006
The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in …
SO Ciurea, K Cao, M Fernandez-Vina, P Kongtim, MA Malki, E Fuchs, ...
Bone marrow transplantation 53 (5), 521-534, 2018
Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease
P Fontaine, G Roy-Proulx, L Knafo, C Baron, DC Roy, C Perreault
Nature medicine 7 (7), 789-794, 2001
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1–2 safety and feasibility study
S Cohen, J Roy, S Lachance, JS Delisle, A Marinier, L Busque, DC Roy, ...
The Lancet Haematology 7 (2), e134-e145, 2020
Minor histocompatibility antigens
C Perreault, F Decary, S Brochu, M Gyger, R Belanger, D Roy
Blood 76 (7), 1269-1280, 1990
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
CJ Walker, JJ Oaks, R Santhanam, P Neviani, JG Harb, G Ferenchak, ...
Blood, The Journal of the American Society of Hematology 122 (17), 3034-3044, 2013
Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment
R Manuguerra-GagnÉ, PR Boulos, A Ammar, FA Leblond, G Krosl, ...
Stem cells 31 (6), 1136-1148, 2013
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
SO Ciurea, MM Al Malki, P Kongtim, EJ Fuchs, L Luznik, XJ Huang, ...
Bone marrow transplantation 55 (1), 12-24, 2020
Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium
DC Roy, R Tantravahi, C Murray, K Dear, B Gorgone, KC Anderson, ...
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2–dependent suppression of C/EBPα-driven myeloid differentiation
JS Chang, R Santhanam, R Trotta, P Neviani, AM Eiring, E Briercheck, ...
Blood, The Journal of the American Society of Hematology 110 (3), 994-1003, 2007
Prediction of graft-versus-host disease in humans by donor gene-expression profiling
C Baron, R Somogyi, LD Greller, V Rineau, P Wilkinson, CR Cho, ...
PLoS medicine 4 (1), e23, 2007
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20